The clinical efficacy of batroxobin in sudden sensorineural hearing loss

ZHAO Hui,JING Jiang-hua,ZHANG Tian-yu,LUO Ji-ning
DOI: https://doi.org/10.3969/j.issn.1672-2922.2007.04.012
2007-01-01
Abstract:Objective To evaluate the efficacy of batroxobin in the management of patients with sudden sensorineural hearing loss. Methods One hundred and eighty patients with sudden hearing loss were included in the present study and were divided into three groups. Group I patients were treated with Salvia miltiorrhiza and dexamethasone (control group). Group II patients were treated with Salvia miltiorrhiza, dexamethasone and batroxobin. Group III patients were treated with Salvia miltiorrhiza and batroxobin. All patients also underwent an associated hypobaric oxygen therapy. Results Sixteen patients due to side effect or uncompliance were withdrawn from the trial. Consequently, the study participants consisted of 53 patients in Group I, 58 patients in group II, and 53 patients in group III, respectively. Their initial audiograms were slop, flat, profound or total deafness type, respectively. The hearing improvement was not significantly different among patients with slop, flat or profound hearing loss audiogram, while patients with total deafness treated with batroxobin (group II and III) showed statistically significant (P < 0.005) hearing improvement more than patients treated with dexamethasone(group I). Hearing improvement in group II and group III was not different between patients with total deafness. Conclusion Greater degree of hearing improvement was achieved in patients with total deafness treated with Batroxobin.
What problem does this paper attempt to address?